Zhou Dong, Yu Haibo, Shao Yuntong, Gao Caixia, Xia Changyou, Qi Yinglin
State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
Heilongjiang Provincial Key Laboratory of Laboratory Animal and Comparative Medicine, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
Front Cell Infect Microbiol. 2025 Sep 1;15:1621012. doi: 10.3389/fcimb.2025.1621012. eCollection 2025.
Bluetongue virus (BTV), a vector-borne pathogen of domestic and wild ruminants, poses substantial global threats to livestock health and trade. Conventional detection methods, such as RT-qPCR, remain constrained by reliance on specialized equipment and prolonged turnaround times, limiting their utility in field settings.
To overcome these challenges, we developed an integrated isothermal amplification-CRISPR detection platform-Reverse Transcription-Enzymatic Recombinase Amplification coupled with CRISPR-Cas13a (RT-ERA/CRISPR-Cas13a)-enabling rapid, sensitive, specific and visual pan-serotype detection of BTV.
The assay demonstrated a sensitivity of 20 RNA copies/reaction within 55 min using three readout modalities: fluorescence values, visual fluorescence signals, and lateral flow test strips. Specificity evaluation revealed no cross-reactivity with 9 non-target pathogens, including epidemiologically significant viruses such as EHDV, AKAV, and CHUV. Clinical validation using 263 field samples demonstrated that RT-ERA/CRISPR-Cas13a achieved clinical sensitivities of 100%, 100%, and 96% with fluorescence values, fluorescence signals, and lateral flow strips, respectively, while maintaining 100% clinical specificity via all modalities. Field adaptation using Nucleic Acid Release Reagent (NARR) simplified crude sample processing, delivering 97% clinical sensitivity and 100% clinical specificity even in the presence of inhibitors from unpurified samples.
This work represents the first CRISPR-Cas13a-based platform for pan-serotype BTV detection, combining portability, cost-efficiency, and detective accuracy suitable for point-of-care deployments. By bridging the gap between high laboratory sensitivity and practical field applicability, this system enables real-time BTV surveillance and facilitates timely outbreak containment in resource-constrained agricultural and veterinary settings.
蓝舌病病毒(BTV)是一种家养和野生反刍动物的媒介传播病原体,对全球牲畜健康和贸易构成重大威胁。传统的检测方法,如逆转录定量聚合酶链反应(RT-qPCR),仍然受到依赖专业设备和较长周转时间的限制,限制了它们在现场环境中的实用性。
为了克服这些挑战,我们开发了一种集成等温扩增-CRISPR检测平台——逆转录-酶促重组酶扩增与CRISPR-Cas13a相结合(RT-ERA/CRISPR-Cas13a),能够对BTV进行快速、灵敏、特异且可视化的泛血清型检测。
该检测方法在55分钟内使用三种读出方式(荧光值、可视化荧光信号和侧向流动试纸条)显示出20个RNA拷贝/反应的灵敏度。特异性评估显示与9种非目标病原体无交叉反应,包括流行病学上重要的病毒,如鹿流行性出血热病毒(EHDV)、阿卡斑病毒(AKAV)和楚布病毒(CHUV)。使用263份现场样本进行的临床验证表明,RT-ERA/CRISPR-Cas13a通过荧光值、荧光信号和侧向流动试纸条分别实现了100%、100%和96%的临床灵敏度,同时通过所有方式保持了100%的临床特异性。使用核酸释放试剂(NARR)进行现场适应性调整简化了粗样本处理,即使在存在未纯化样本中的抑制剂的情况下,仍能提供97%的临床灵敏度和100%的临床特异性。
这项工作代表了首个基于CRISPR-Cas13a的泛血清型BTV检测平台,结合了便携性、成本效益和检测准确性,适用于即时检测部署。通过弥合高实验室灵敏度与实际现场适用性之间的差距,该系统能够进行实时BTV监测,并有助于在资源有限的农业和兽医环境中及时控制疫情爆发。